Magnolol and Honokiol: Two Natural Compounds with Similar Chemical Structure but Different Physicochemical and Stability Properties
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Magnolol and Honokiol: Two Natural Compounds with Similar Chemical Structure but Different Physicochemical and Stability Properties
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 2, Pages 224
Publisher
MDPI AG
Online
2021-02-08
DOI
10.3390/pharmaceutics13020224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison between Citral and Pompia Essential Oil Loaded in Phospholipid Vesicles for the Treatment of Skin and Mucosal Infections
- (2020) Iris Usach et al. Nanomaterials
- Toxicity and possible mechanisms of action of honokiol from Magnolia denudata seeds against four mosquito species
- (2019) Zhangqian Wang et al. Scientific Reports
- Insights on the Multifunctional Activities of Magnolol
- (2019) Jianhong Zhang et al. Biomed Research International
- Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation
- (2019) Wang et al. Pharmaceutics
- Honokiol: A Review of Its Anticancer Potential and Mechanisms
- (2019) Chon Phin Ong et al. Cancers
- Thymus essential oil extraction, characterization and incorporation in phospholipid vesicles for the antioxidant/antibacterial treatment of oral cavity diseases
- (2018) Maria Manconi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Magnolol treatment attenuates dextran sulphate sodium-induced murine experimental colitis by regulating inflammation and mucosal damage
- (2018) Peng Shen et al. LIFE SCIENCES
- Magnolol promotes thermogenesis and attenuates oxidative stress in 3T3-L1 adipocytes
- (2018) Hilal Ahmad Parray et al. NUTRITION
- Safety and Toxicology of Magnolol and Honokiol
- (2018) Andrea Sarrica et al. PLANTA MEDICA
- Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer
- (2018) Abhishek Ranaware et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
- (2018) Weiwei Wu et al. International Journal of Nanomedicine
- Improved oral bioavailability of magnolol by using a binary mixed micelle system
- (2018) Pinggang Ding et al. Artificial Cells Nanomedicine and Biotechnology
- Magnolol Nanoparticles Exhibit Improved Water Solubility and Suppress TNF-α-Induced VCAM-1 Expression in Endothelial Cells
- (2017) Chiang-Wen Lee et al. Journal of Biomedical Nanotechnology
- Activation of Nrf2/HO-1signaling pathway involves the anti-inflammatory activity of magnolol in Porphyromonas gingivalis lipopolysaccharide-stimulated mouse RAW 264.7 macrophages
- (2015) Sheng-Hua Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Effects of Magnolol and Honokiol on Adhesion, Yeast-Hyphal Transition, and Formation of Biofilm by Candida albicans
- (2015) Lingmei Sun et al. PLoS One
- Honokiol nanosuspensions: Preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system
- (2014) Meihua Han et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Drug delivery vehicles on a nano-engineering perspective
- (2014) Betiana Felice et al. Materials Science & Engineering C-Materials for Biological Applications
- Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine
- (2014) Jiann-Hwa Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone
- (2013) Shiuan-Pey Lin et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- The influence of lipophilicity in drug discovery and design
- (2012) John A Arnott et al. Expert Opinion on Drug Discovery
- Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA
- (2011) Chao Zhao et al. BIOCHIMIE
- Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes
- (2011) Maria Coimbra et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Therapeutic applications of compounds in the Magnolia family
- (2011) Young-Jung Lee et al. PHARMACOLOGY & THERAPEUTICS
- Quality Assessment of Commercial Magnoliae Officinalis Cortex by 1H-NMR-based Metabolomics and HPLC Methods
- (2011) Yong Jiang et al. PHYTOCHEMICAL ANALYSIS
- Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
- (2010) Subash C. Gupta et al. CANCER AND METASTASIS REVIEWS
- Neuroprotective effect of honokiol and magnolol, compounds from Magnolia officinalis, on beta-amyloid-induced toxicity in PC12 cells
- (2010) Chu Peng Hoi et al. PHYTOTHERAPY RESEARCH
- Antiinflammatory activity of methanol extract isolated from stem bark ofMagnolia kobus
- (2008) Jong Soon Kang et al. PHYTOTHERAPY RESEARCH
- Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents
- (2007) Qun Xu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started